Traws Pharma, Inc.TRAWNASDAQ
Loading
Year-over-year research & development expense growth
Latest
-10.35%
↓ 317% vs avg
Percentile
P35
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
4.78%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | -10.35% |
| Q4 2024 | 167.31% |
| Q2 2024 | -60.93% |
| Q4 2023 | -25.12% |
| Q2 2023 | -11.22% |
| Q4 2022 | 82.23% |
| Q2 2022 | 15.30% |
| Q4 2021 | -7.52% |
| Q2 2021 | -56.58% |
| Q4 2020 | 6.80% |
| Q2 2020 | 7.97% |
| Q4 2019 | -5.04% |
| Q2 2019 | -3.42% |
| Q4 2018 | -4.24% |
| Q2 2018 | -10.03% |
| Q4 2017 | 1.32% |
| Q2 2017 | 8.84% |
| Q4 2016 | -23.72% |
| Q2 2016 | 15.18% |
| Q4 2015 | -38.26% |
| Q2 2015 | -28.12% |
| Q4 2014 | -17.97% |
| Q2 2014 | -0.83% |
| Q4 2013 | 20.07% |
| Q2 2013 | -39.25% |
| Q4 2012 | 146.57% |
| Q2 2012 | 0.00% |